Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
27 Sep 2023
Update on Challenges in Diagnosis and Treatment of Myeloid Neoplasms with Systemic Mastocytosis
Concurrent systemic mastocytosis (SM) may often be missed in patients with myeloid neoplasms, such as, chronic myelomonocytic…
26 Sep 2023
The Beginning of a New Era: Where Are We Going with Immunotherapies in Resectable NSCLC?
At the European Society for Thoracic Surgeons (ESTS) 2023 Conference Erin Gillaspie, Department of Thoracic Surgery, Vanderbilt…
26 Sep 2023
On-Demand Content - Past, Present, and Future of Personalized Care in Lung Cancer: HER2-Targeted and DLL3-Targeted Therapies in Focus
Access the exclusive video of Boehringer Ingelheim’s Industry Sponsored Symposium at the International Association for the Study of Lung…
5
Mins
18 Sep 2023
Hansen's Disease with Pure Nerve Involvement
Leprosy, also known as Hansen’s disease, is a chronic granulomatous infection. It is non-fatal and slowly progressive. Its causative…
21 Aug 2023
Introducing Mavacamten for the Treatment of NYHA Class II and III Symptomatic Obstructive HCM in Adult Patients
This infographic explores mavacamten, the first cardiac myosin inhibitor for New York Heart Association (NYHA) Class II and III…
12
Mins
15 Aug 2023
Diagnosing Fabry Disease: Practical Clinical Recommendations and Guidance for Patients with Fabry Disease
This article was funded by Sanofi and is intended for healthcare professionals.
11
Mins
15 Aug 2023
Focal Onset Seizures: New Treatment Options in The Clinical Practice
Carreño began by discussing the spectrum of uncontrolled epilepsies. They stressed that uncontrolled epilepsy does not necessarily…
7
Mins
15 Aug 2023
Interview: Dirk Devroey
I undertook my university courses at University Hospitals, and at several other hospitals in Belgium, but I also had some training in…
15 Aug 2023
Retracted: A Spotlight on Friedreich Ataxia: Optimising the Patient Journey from Diagnosis to Disease Management
This article has now been retracted and a retraction statement has been published.
6
Mins
15 Aug 2023
Development of the Clinical Myotonia Rating Scale and a Mexiletine Prescribing and Monitoring Algorithm for Patients with Non-Dystrophic Myotonia
In the rare neuromuscular disorders classed as NDM, muscle stiffness (myotonia) is the major symptom and is defined by a delayed muscle…
←
1
2
3
…
6
7
8
9
10
11
12
…
35
36
37
→
We’ve noticed you’re accessing
from
North/South America.
View
View